title: Effect of calcium and magnesium on the antimicrobial action of enterocin LR/6 produced by Enterococcus faecium LR/6.
abstract: Enterococci are well-known producers of antimicrobial peptides (enterocins) that possess potential as biopreservatives in food. In this study, divalent cations and release of intracellular potassium were used to assess the mechanism of interaction and killing of enterocin LR/6 produced by Enterococcus faecium LR/6 on three target Gram-positive and Gram-negative bacteria, namely Micrococcus luteus, Enterococcus sp. strain LR/3 and Escherichia coli K-12. Whilst treatment with enterocin LR/6 in all cases led to a significant loss of viability, suggesting a bactericidal mode of action, E. coli K-12 showed better tolerance than the other two strains. Bacteriocins have generally been reported to create pores in the membrane of sensitive cells and this function is diminished by divalent cations. In this study it was shown that Ca(2+) and Mg(2+) markedly improved the viability of enterocin LR/6-treated cells in a concentration-dependent manner. K(+) release as a sign of membrane leakiness was higher in M. luteus compared with the other two test strains. In agreement with the viability response, pre-exposure to Ca(2+) and Mg(2+) substantially reduced the amount of K(+) leakage by M. luteus and Enterococcus sp.; in the case of E. coli K-12, no leakage of K(+) was recorded. These results suggest that enterocin LR/6, which possesses good antibacterial potential, may not be very effective as a preservative in foods containing high concentrations of calcium and magnesium.
authors.affiliation: Department of Genetics, University of Delhi South Campus, New Delhi 110021, India.
authors.forename: Manoj
authors.initials: M
authors.lastname: Kumar
authors.forename: Sheela
authors.initials: S
authors.lastname: Srivastava
mesh_terms: D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology*; D001952:Bridged-Ring Compounds / Q000378:metabolism / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D003067:Coenzymes / Q000378:metabolism; D016984:Enterococcus faecium / Q000187:drug effects* / Q000378:metabolism; D048168:Escherichia coli K12 / Q000187:drug effects*; D006801:Humans; D008274:Magnesium / Q000378:metabolism*; D050296:Microbial Viability / Q000187:drug effects; D016982:Micrococcus luteus / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D001952:Bridged-Ring Compounds; D003067:Coenzymes; C012306:enterocin; D008274:Magnesium; D002118:Calcium